🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
10.72
-0.51 (-4.54%)
At close: Nov 20, 2026, 4:00 PM EST
10.86
+0.14 (1.32%)
After-hours: Nov 20, 2026, 7:42 PM EST

Gossamer Bio Stock Forecast

GOSS's stock price has decreased by -95.73% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 8 analysts polled by S&P Global, Gossamer Bio stock has a consensus rating of "Buy" and an average price target of $83.4. The average 1-year stock price forecast is 677.99% higher than the current stock price, while the lowest is $22.4 (+108.96%) and the highest is $160 (+1,392.54%).

Price Target: $83.4 (+677.99%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$22.4$83.4$93$160
Change+108.96%+677.99%+767.54%+1392.5%

Analyst Ratings

The average analyst rating for Gossamer Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy122233
Buy111111
Hold433333
Sell111111
Strong Sell000000
Total777788

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$90
BuyReiterates$90+739.55%Nov 16, 2026
Unknown Analyst
Guggenheim
No rating
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aNov 12, 2026
Chardan Capital
Chardan Capital
Buy
Initiates
$160
BuyInitiates$160+1,392.54%Oct 13, 2026
Wedbush
Wedbush
Hold
Maintains
$80
HoldMaintains$80+646.27%Aug 14, 2026
Barclays
Barclays
Sell
Maintains
$22
SellMaintains$22+108.96%Jul 28, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
64.61M
from 48.47M
Increased by 33.31%
Revenue Next Year
17.98M
from 64.61M
Decreased by -72.18%
EPS This Year
-18.88
from -60.00
EPS Next Year
-12.16
from -18.88
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---114.70M48.47M64.61M
Revenue Growth
-----57.74%33.31%
Gross Profit
---114.70M48.47M64.61M
Gross Margin
---100.00%100.00%100.00%
Operating Income
-216.05M-218.53M-173.76M-59.92M-163.25M-94.45M
Net Income
-234.00M-229.38M-179.82M-56.53M-170.37M-109.94M
EPS
-----60.00-18.88
Free Cash Flow
-----171.35M-150.20M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High64.6M
Avg64.6M
Low64.6M

Revenue Growth

Revenue Growth202620272028
High
33.3%
Avg
33.3%
Low
33.3%

EPS Forecast

EPS202620272028
High-17.60
Avg-18.88
Low-20.16

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-